• Merck & Co. Inc., of Whitehouse Station, N.J., said the FDA approved Zioptan (tafluprost ophthalmic solution) 0.0015 percent, a preservative-free prostaglandin analogue ophthalmic solution for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.